Cancer Global Summit-CGS 2026

Targeted drug design is a cornerstone strategy in oncology, aiming to design drugs that target cancer cells selectively with minimal effect on normal tissues. The lecture "Targeted Drug Design" discusses the principles, strategies, and innovations involved in developing highly specific cancer therapies.".

This strategy focuses on the identification of molecular targets, including oncogenes, tumor suppressors, or signaling pathways, that contribute to cancer cell growth and survival. High-throughput screening, advanced computational modeling, and structure-based drug design are used to find molecules that bind specifically to these targets. Targeted drugs focus on tumor-specific mechanisms to enhance therapeutic effects and minimize systemic toxicity over traditional chemotherapy.

The meeting also emphasizes combination regimens, biomarker-guided treatment, and adaptive design methods that maximize patient benefit. Integration with genomics, proteomics, and bioinformatics enables clinicians to pair targeted agents with the unique profiles of individual tumors, moving precision oncology forward. New innovations, such as nanomedicine, antibody-drug conjugates, and AI-enabled drug discovery, are revolutionizing the pace and precision of drug development.

Participants will hear about the process of drug design, clinical use, and prospects for targeted therapy. This session highlights how precision-targeted drugs are transforming the treatment of cancer, enhancing survival, reducing side effects, and defining the next generation of personalized oncology.